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Abstract
© 2017 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. This paper
reports an entirely unexplored concept of simultaneously recognizing two receptors using high-
and low-affinity ligands through ligating them in situ on the target cell surface. This de novo
approach is inspired by the pretargeting strategy frequently applied in molecular imaging, and
has now evolved as the basis of a new paradigm for visualizing target cells with a high imaging
contrast. A distinct advantage of using a labeled low-affinity ligand such as glycan is that the
excess labeled ligand can be washed away from the cells, whereas the ligand bound to the cell,
even at the milli  molar affinity level,  can be anchored by a bioorthogonal reaction with a
pretargeted  high-affinity  ligand  on  the  surface.  Consequently,  nonspecific  background  is
minimized, leading to improved imaging contrast. Importantly, despite previously unexplored for
molecular imaging, a notoriously weak glycan/lectin interaction can now be utilized as a highly
selective ligand to the targets.
http://dx.doi.org/10.1002/advs.201700147
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